Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LTB4R | Q15722 | 6/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 6/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5023638 | 1.00 | VDR (0.52) | VDRALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL2781788 | 0.75 | VDR (0.70) | VDR | |
| SCHEMBL18986283 | 0.73 | VDR (0.56) | VDRALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL18986268 | 0.73 | VDR (0.56) | VDRALDH1A1KDM4EMEN1MAPT | |
| SCHEMBL3280250 | 0.71 | VDR (0.53) | VDRLTB4RPTGS1PTGS2 | |
| SCHEMBL6155591 | 0.71 | VDR (0.62) | VDRALDH1A1KDM4ERECQLLMNA | |
| SCHEMBL6155010 | 0.71 | KMT2A (0.41) | VDRALDH1A1MEN1MAPTHPGD | |
| SCHEMBL6158239 | 0.71 | KMT2A (0.41) | VDRALDH1A1MEN1MAPTHPGD | |
| SCHEMBL18986501 | 0.70 | VDR (0.50) | VDR | |
| SCHEMBL19020525 | 0.69 | VDR (0.49) | VDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592452-B1 | INVERT EMULSION TYPE COMPOSITION CONTAINING AT LEAST ONE ACTIVE AGENT SENSITIVE TO THE PRESENCE OF WATER, AND ITS USES IN COSMETICS AND IN DERMATOLOGY | GALDERMA RES & DEV (FR) | 2008-10-08 | — | — | EP | claimed |
| US-20070135379-A1 | Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135379-A1 | Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle | IDUA, ARSA, STS | VDR 3900/4885ALDH1A1 1466/4885KDM4E 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.